infectious disease

Biotech Red Queen launches with $55M to build versatile antivirals
BioPharma Dive
Tue, 08/6/24 - 11:32 am
Red Queen Therapeutics
infectious disease
influenza
COVID-19
Apple Tree Partners
Two genomics powerhouses team up to expand infectious disease surveillance
Stat
Thu, 01/25/24 - 11:11 am
infectious disease
Wellcome Sanger Institute
Centre for Epidemic Response and Innovation
J&J ends R&D at Janssen's infectious disease and vaccine unit
Fierce Biotech
Wed, 08/23/23 - 05:40 pm
JNJ
infectious disease
vaccines
R&D
Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts
Fierce Biotech
Thu, 07/20/23 - 10:18 am
JNJ
Janssen
infectious disease
vaccines
hepatitis
HIV
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Fierce Biotech
Tue, 04/18/23 - 10:13 am
JNJ
Janssen
earnings
restructuring
infectious disease
Merck Makes Another Big R&D Investment with $3.5B Orna Deal
BioSpace
Tue, 08/16/22 - 12:10 pm
Merck
RNA
Orna Therapeutics
oncology
infectious disease
Moderna founder launches Apriori with $50M to stay ahead of virus variants
BioPharma Dive
Mon, 07/11/22 - 05:55 pm
Flagship Pioneering
Moderna
Apriori
infectious disease
COVID-19
GSK pledges £1bn drive for infectious disease R&D
Pharmaforum
Fri, 06/24/22 - 10:23 am
GSK
R&D
infectious disease
Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron
Endpoints
Tue, 11/23/21 - 09:51 am
Vaccibody
Nykode Therapeutics
Regeneron
biobucks
cancer
infectious disease
GSK outlines ambitious 10-year plan, but hits investors' near-term outlook
BioPharma Dive
Wed, 06/23/21 - 10:29 pm
GSK
investors
cancer
Immune
infectious disease